by apacmed apacmed

MedTech Industry Footprint Project – In Collaboration with KPMG

Download the PDF here

By 2020, Asia Pacific will be the second biggest market for MedTech, behind the US, and ahead of the EU. Home to over half of the world’s population, the region counts more than 50 % of the world’s chronic disease burden and nearly 60% of the world’s ageing population.

The objectives of the MedTech Industry Footprint Project is twofold:  

  • Quantify the MedTech industry footprint across the region
  • Provide the evidence base for APACMed and Members’ advocacy efforts

The project involved both desk research and some statistical modelling, to gather over 250+ data points across 20 attributes around 5 overarching themes:

  • Understanding the Market
  • Fostering Innovation
  • Contribution to Society
  • Challenges Faced Business Ethics and Compliance